<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39693149</PMID><DateCompleted><Year>2025</Year><Month>02</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>The Value of Infrapyloric Lymph Nodes Dissection in Right Hemicolectomy for Hepatic Flexure Colon Cancer: A Multicenter Analysis Based on Propensity Score Matching.</ArticleTitle><Pagination><StartPage>338</StartPage><EndPage>350</EndPage><MedlinePgn>338-350</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003356</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There is a dispute regarding the necessity of infrapyloric lymph node dissection in right hemicolectomy for hepatic flexure colon cancer.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the risk factors for infrapyloric lymph node metastasis and the prognostic role of infrapyloric lymph node dissection in patients with hepatic flexure colon cancer and identify the population of patients who would benefit from infrapyloric lymph node dissection.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective multicenter propensity score matching study to minimize heterogeneity between 2 groups.</AbstractText><AbstractText Label="SETTINGS" NlmCategory="METHODS">This study was conducted at 3 medical centers.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">A total of 531 patients who underwent curative resection for hepatic flexure colon cancer were included.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">The primary outcome measure was the metastasis rate of infrapyloric lymph nodes, whereas secondary outcome measure included overall survival. Logistic regression analysis was used to identify risk factors, and Kaplan-Meier analysis was used to evaluate survival outcomes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The metastasis rate of infrapyloric lymph nodes among patients undergoing infrapyloric lymph node dissection was 11.8% (26/221). Cox multivariate analysis confirmed that infrapyloric lymph node dissection was an independent prognostic factor after propensity score matching (HR 0.60; 95% CI, 0.38-0.84; p = 0.007). A proposed flowchart for infrapyloric lymph node dissection based on preoperative factors was created. Based on the proposed flowchart, patients with preoperative serum CEA level &#x2264;5.0&#x2009;ng/mL, cN + , and tumor size &#x2265;5&#x2009;cm and patients with preoperative serum CEA level &gt;5.0&#x2009;ng/mL were identified as the high-priority infrapyloric lymph node dissection group. The metastasis rate of infrapyloric lymph nodes in the high-priority group was 16.0% (20/125). In the high-priority group, patients undergoing infrapyloric lymph node dissection had better survival outcomes than those not undergoing infrapyloric lymph node dissection ( p = 0.005).</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">This study is limited by its retrospective nature.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study suggests that infrapyloric lymph node dissection should be performed in specific patients with hepatic flexure colon cancer. See Video Abstract .</AbstractText><AbstractText Label="EL VALOR DE LA DISECCIN DE LOS GANGLIOS LINFTICOS INFRA PILRICOS EN LA HEMICOLECTOMA DERECHA PARA EL CNCER DE COLON DEL ANGULO HEPTICO UN ANLISIS MULTICNTRICO BASADO EN EL EMPAREJAMIENTO POR PUNTAJE DE PROPENSIN" NlmCategory="UNASSIGNED">ANTECEDENTES:Existe controversia sobre la necesidad de la disecci&#xf3;n de los ganglios linf&#xe1;ticos infra pil&#xf3;ricos en la hemicolectom&#xed;a derecha por c&#xe1;ncer de colon del &#xe1;ngulo hep&#xe1;tico.OBJETIVO:Evaluar los factores de riesgo de met&#xe1;stasis de los ganglios linf&#xe1;ticos infra pil&#xf3;ricos y el papel pron&#xf3;stico de la disecci&#xf3;n de los ganglios linf&#xe1;ticos infra pil&#xf3;ricos en pacientes con c&#xe1;ncer de colon del &#xe1;ngulo hep&#xe1;tico e identificar la poblaci&#xf3;n que se beneficiar&#xed;a de la disecci&#xf3;n de los ganglios linf&#xe1;ticos infra pil&#xf3;ricos.DISE&#xd1;O:Estudio retrospectivo multic&#xe9;ntrico de emparejamiento por puntaje de propensi&#xf3;n para minimizar la heterogeneidad entre dos grupos.AJUSTE:Estudio realizando en tres centros m&#xe9;dicos.PACIENTES:Un total de 531 pacientes sometidos a una resecci&#xf3;n curativa por c&#xe1;ncer de colon del &#xe1;ngulo hep&#xe1;tico.PRINCIPALES MEDIDAS DE RESULTADO:Se utiliz&#xf3; un an&#xe1;lisis log&#xed;stico para evaluar los factores de riesgo de met&#xe1;stasis de los ganglios linf&#xe1;ticos infra pil&#xf3;ricos y se utiliz&#xf3; el an&#xe1;lisis de Kaplan-Meier para evaluar la supervivencia general.RESULTADOS:La tasa de met&#xe1;stasis de los ganglios linf&#xe1;ticos infra pil&#xf3;ricos entre los pacientes sometidos a disecci&#xf3;n de ganglios linf&#xe1;ticos infra pil&#xf3;ricos fue del 11,8 % (26/221). El an&#xe1;lisis multivariable de Cox confirm&#xf3; que la disecci&#xf3;n de ganglios linf&#xe1;ticos infra pil&#xf3;ricos era un factor pron&#xf3;stico independiente despu&#xe9;s de la comparaci&#xf3;n por puntuaci&#xf3;n de propensi&#xf3;n (cociente de riesgos instant&#xe1;neos 0,60; IC del 95 %, 0,38 a 0,84; p = 0,007). Se cre&#xf3; un diagrama de flujo propuesto para la disecci&#xf3;n de ganglios linf&#xe1;ticos infra pil&#xf3;ricos basado en factores preoperatorios. Con base en el diagrama de flujo propuesto, los pacientes con un nivel de CEA s&#xe9;rico preoperatorio &#x2264;5,0&#x2009;ng/ml, cN+ y un tama&#xf1;o tumoral &#x2265;5&#x2009;cm, y los pacientes con un nivel de CEA s&#xe9;rico preoperatorio &gt;5,0&#x2009;ng/ml se definieron como grupo de disecci&#xf3;n de ganglios linf&#xe1;ticos infra pil&#xf3;ricos de alta prioridad. La tasa de met&#xe1;stasis de los ganglios linf&#xe1;ticos infra pil&#xf3;ricos en el grupo de alta prioridad fue del 16,0 % (20/125). En el grupo de alta prioridad, los pacientes sometidos a disecci&#xf3;n de ganglios linf&#xe1;ticos infra pil&#xf3;ricos tuvieron mejores resultados de supervivencia que aquellos que no se sometieron a disecci&#xf3;n de ganglios linf&#xe1;ticos infra pil&#xf3;ricos ( p = 0,005).LIMITACIONES:Estudio limitado por su naturaleza retrospectiva.CONCLUSIONES:El estudio sugiere que la disecci&#xf3;n de ganglios linf&#xe1;ticos infra pil&#xf3;ricos se debe realizar en pacientes espec&#xed;ficos con c&#xe1;ncer de colon del &#xe1;ngulo hep&#xe1;tico. (Traducci&#xf3;n: Dr. Fidel Ruiz Healy ).</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Colon and Rectal Surgeons.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Colorectal Cancer Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of the University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Xian-Wen</ForeName><Initials>XW</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Surgery, Central South University Xiangya School of Medicine Affiliated Haikou Hospital, Haikou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Surgery, Chengdu Second People's Hospital, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Colorectal Cancer Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of the University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Yang-Chun</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Colorectal Cancer Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of the University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Colorectal Cancer Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of the University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Colorectal Cancer Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of the University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Hai</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Colorectal Cancer Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of the University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="Y">Lymph Node Excision</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003110" MajorTopicYN="Y">Colonic Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003082" MajorTopicYN="Y">Colectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044684" MajorTopicYN="Y">Colon, Transverse</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008198" MajorTopicYN="Y">Lymph Nodes</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>20</Day><Hour>18</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>18</Day><Hour>18</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>18</Day><Hour>12</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>2</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39693149</ArticleId><ArticleId IdType="pmc">PMC11837961</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003356</ArticleId><ArticleId IdType="pii">00003453-990000000-00819</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Xu L, Su X, He Z, et al. ; RELARC Study Group. Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial. Lancet Oncol. 2021;22:391&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pubmed">33587893</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation&#x2014;technical notes and outcome. Colorectal Dis. 2009;11:354&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pubmed">19016817</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanemitsu Y, Komori K, Kimura K, Kato T. D3 lymph node dissection in right hemicolectomy with a no-touch isolation technique in patients with colon cancer. Dis Colon Rectum. 2013;56:815&#x2013;824.</Citation><ArticleIdList><ArticleId IdType="pubmed">23739187</ArticleId></ArticleIdList></Reference><Reference><Citation>Kataoka K, Beppu N, Shiozawa M, et al. . Colorectal cancer treated by resection and extended lymphadenectomy: patterns of spread in left- and right-sided tumours. Br J Surg. 2020;107:1070&#x2013;1078.</Citation><ArticleIdList><ArticleId IdType="pubmed">32246469</ArticleId></ArticleIdList></Reference><Reference><Citation>Piozzi GN, Rusli SM, Baek SJ, Kwak JM, Kim J, Kim SH. Infrapyloric and gastroepiploic node dissection for hepatic flexure and transverse colon cancer: a systematic review. Eur J Surg Oncol. 2022;48:718&#x2013;726.</Citation><ArticleIdList><ArticleId IdType="pubmed">34893366</ArticleId></ArticleIdList></Reference><Reference><Citation>Uematsu D, Akiyama G, Sugihara T, Magishi A, Yamaguchi T, Sano T. Laparoscopic radical lymph node dissection for advanced colon cancer close to the hepatic flexure. Asian J Endosc Surg. 2017;10:23&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">27515772</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertelsen CA, Bols B, Ingeholm P, et al. . Lymph node metastases in the gastrocolic ligament in patients with colon cancer. Dis Colon Rectum. 2014;57:839&#x2013;845.</Citation><ArticleIdList><ArticleId IdType="pubmed">24901684</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyota S, Ohta H, Anazawa S. Rationale for extent of lymph node dissection for right colon cancer. Dis Colon Rectum. 1995;38:705&#x2013;711.</Citation><ArticleIdList><ArticleId IdType="pubmed">7607029</ArticleId></ArticleIdList></Reference><Reference><Citation>Sj&#xf6;vall A, Granath F, Cedermark B, Glimelius B, Holm T. Loco-regional recurrence from colon cancer: a population-based study. Ann Surg Oncol. 2007;14:432&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pubmed">17139459</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha S, Johnston G, Korant A, et al. . Aberrant drainage of sentinel lymph nodes in colon cancer and its impact on staging and extent of operation. Am J Surg. 2013;205:302&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">23414953</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessler H, Hohenberger W. Extended lymphadenectomy in colon cancer is crucial. World J Surg. 2013;37:1789&#x2013;1798.</Citation><ArticleIdList><ArticleId IdType="pubmed">23754141</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiser MR. AJCC 8th edition: colorectal cancer. Ann Surg Oncol. 2018;25:1454&#x2013;1455.</Citation><ArticleIdList><ArticleId IdType="pubmed">29616422</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014;12:1495&#x2013;1499.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez LM, Parlade AJ, Wasser EJ, et al. . How reliable Is CT scan in staging right colon cancer? Dis Colon Rectum. 2019;62:960&#x2013;964.</Citation><ArticleIdList><ArticleId IdType="pubmed">30870227</ArticleId></ArticleIdList></Reference><Reference><Citation>Burton S, Brown G, Bees N, et al. . Accuracy of CT prediction of poor prognostic features in colonic cancer. Br J Radiol. 2008;81:10&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">17967848</ArticleId></ArticleIdList></Reference><Reference><Citation>Sibileau E, Ridereau-Zins C, Vanel D, et al. . Accuracy of water-enema multidetector computed tomography (WE-MDCT) in colon cancer staging: a prospective study. Abdom Imaging. 2014;39:941&#x2013;948.</Citation><ArticleIdList><ArticleId IdType="pubmed">24811763</ArticleId></ArticleIdList></Reference><Reference><Citation>Maggiori L, Rullier E, Lefevre JH, et al. . Does a combination of laparoscopic approach and full fast track multimodal management decrease postoperative morbidity? A multicenter randomized controlled trial. Ann Surg. 2017;266:729&#x2013;737.</Citation><ArticleIdList><ArticleId IdType="pubmed">28806303</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashiguchi Y, Muro K, Saito Y, et al. ; Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25:1&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6946738</ArticleId><ArticleId IdType="pubmed">31203527</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrido MM, Kelley AS, Paris J, et al. . Methods for constructing and assessing propensity scores. Health Serv Res. 2014;49:1701&#x2013;1720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4213057</ArticleId><ArticleId IdType="pubmed">24779867</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46:399&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3144483</ArticleId><ArticleId IdType="pubmed">21818162</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985;39:33&#x2013;38.</Citation></Reference><Reference><Citation>Rubin DB, Thomas N. Matching using estimated propensity scores: relating theory to practice. Biometrics. 1996;52:249&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">8934595</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta J, McMillan MT, Ecker BL, et al. . Implications of lymph node staging on selection of adjuvant therapy for gastric cancer in the united states: a propensity score-matched analysis. Ann Surg. 2016;263:298&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">26135687</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng B, Sun J, Ling TL, et al. . Laparoscopic complete mesocolic excision (CME) with medial access for right-hemi colon cancer: feasibility and technical strategies. Surg Endosc. 2012;26:3669&#x2013;3675.</Citation><ArticleIdList><ArticleId IdType="pubmed">22733200</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng B, Ling TL, Lu AG, et al. . Completely medial versus hybrid medial approach for laparoscopic complete mesocolic excision in right hemicolon cancer. Surg Endosc. 2014;28:477&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pubmed">24114515</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Huang S, Lu X, Huang Y, Chi P. Incidence of and risk factors for gastroepiploic lymph node involvement in patients with cancer of the transverse colon including the hepatic flexure. World J Surg. 2021;45:1514&#x2013;1525.</Citation><ArticleIdList><ArticleId IdType="pubmed">33475804</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Y, Huang S, Huang M, Wang X, Huang Y, Chi P. Gastrocolic ligament lymph-node dissection may increase the incidence of delayed gastric emptying after colon cancer surgery with D3 lymphadenectomy. Surg Today. 2021;51:897&#x2013;905.</Citation><ArticleIdList><ArticleId IdType="pubmed">33389191</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Su Y, Liu X, Zhuang J, Yang Y, Guan G. Clinical analysis of metastatic characteristics of infrapyloric lymph nodes (No.206) and terminal ileum lymph nodes in patients with right colon cancer. World J Surg Oncol. 2021;19:310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8532261</ArticleId><ArticleId IdType="pubmed">34674722</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Zhang D, Feng Y, et al. . Infrapyloric lymph node dissection in right hemicolectomy for colon cancer: should prophylactic resection be recommended? J Surg Oncol. 2021;123(suppl 1):S30&#x2013;S35.</Citation><ArticleIdList><ArticleId IdType="pubmed">33646617</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrakis A, Weber K, Merkel S, et al. . Lymph node metastasis of carcinomas of transverse colon including flexures. Consideration of the extramesocolic lymph node stations. Int J Colorectal Dis. 2014;29:1223&#x2013;1229.</Citation><ArticleIdList><ArticleId IdType="pubmed">25060216</ArticleId></ArticleIdList></Reference><Reference><Citation>Popescu RC, Botea F, Dumitru E, et al. . Extended lymphadenectomy for proximal transverse colon cancer: is there a place for standardization? Medicina (Kaunas). 2022;58:596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9145310</ArticleId><ArticleId IdType="pubmed">35630013</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27276019</PMID><DateCompleted><Year>2017</Year><Month>10</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1518-8345</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>Revista latino-americana de enfermagem</Title><ISOAbbreviation>Rev Lat Am Enfermagem</ISOAbbreviation></Journal><ArticleTitle>Pharmaceutical interventions in medications prescribed for administration via enteral tubes in a teaching hospital.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e2696</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1590/1518-8345.0619.2696</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0104-11692016000100329</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">to analyze the impact of guidelines regarding errors in medications prescribed for administration through enteral tubes.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">quantitative study, in three phases, undertaken in internal medicine, neurology and an intensive care unit in a general teaching hospital. In Phase 1, the following was undertaken: a protocol for dilution and unit-dose repackaging and administration for 294 medications via enteral tubes; a decision flowchart; operational-standard procedures for dilution and unit-dose repackaging of oral pharmaceutical forms and for administration of medications through enteral tubes. In phase 2, errors in 872 medications prescribed through enteral tubes, in 293 prescriptions for patients receiving inpatient treatment between March and June, were investigated. This was followed by training of the teams in relation to the guidelines established. In Phase 3, pharmaceutical errors and interventions in 945 medications prescribed through enteral tubes, in 292 prescriptions of patients receiving inpatient treatment between August and September, were investigated prospectively. The data collected, in a structured questionnaire, were compiled in the Microsoft Office Excel(r) program, and frequencies were calculated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">786 errors were observed, 63.9% (502) in Phase 2, and 36.1% (284) in Phase 3. In Phase 3, a reduction was ascertained in the frequency of prescription of medications delivered via enteral tubes, medications which were contraindicated, and those for which information was not available.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">guidelines and pharmaceutical interventions were determined in the prevention of errors involving medications delivered through enteral tubes.</AbstractText><AbstractText Label="OBJETIVO" NlmCategory="OBJECTIVE">analisar o impacto de diretrizes sobre erros em medicamentos prescritos para administra&#xe7;&#xe3;o via sondas enterais.</AbstractText><AbstractText Label="M&#xc9;TODO" NlmCategory="UNASSIGNED">estudo quantitativo, em tr&#xea;s fases, realizado em cl&#xed;nica m&#xe9;dica, neurologia e unidade de terapia intensiva de hospital geral universit&#xe1;rio. Na Fase 1 elaborou-se: protocolo de dilui&#xe7;&#xe3;o, unitariza&#xe7;&#xe3;o - transforma&#xe7;&#xe3;o e administra&#xe7;&#xe3;o para 294 medicamentos via sondas enterais; fluxograma decis&#xf3;rio; procedimentos operacionais-padr&#xe3;o de dilui&#xe7;&#xe3;o e unitariza&#xe7;&#xe3;o de formas farmac&#xea;uticas orais e de administra&#xe7;&#xe3;o de medicamentos via sondas enterais. Na Fase 2 investigou-se, retrospectivamente, erros em 872 medicamentos prescritos via sondas enterais, em 293 prescri&#xe7;&#xf5;es de pacientes internados de mar&#xe7;o a junho. Seguiu-se capacita&#xe7;&#xe3;o das equipes sobre diretrizes estabelecidas. Na Fase 3 investigou-se, prospectivamente, erros e interven&#xe7;&#xf5;es farmac&#xea;uticas em 945 medicamentos prescritos via sondas enterais, em 292 prescri&#xe7;&#xf5;es de pacientes internados de agosto a setembro. Dados coletados, em formul&#xe1;rio estruturado, foram compilados no programa Microsoft Office Excel(r) e calculadas as frequ&#xea;ncias.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">foram observados 786 erros, 63,9% (502) na Fase 2 e 36,1% (284) na Fase 3. Na Fase 3 verificou-se redu&#xe7;&#xe3;o na frequ&#xea;ncia de prescri&#xe7;&#xe3;o de medicamentos, via sondas enterais, contraindicados e sem informa&#xe7;&#xf5;es dispon&#xed;veis.</AbstractText><AbstractText Label="CONCLUS&#xc3;O" NlmCategory="UNASSIGNED">diretrizes e interven&#xe7;&#xf5;es farmac&#xea;uticas foram determinantes na preven&#xe7;&#xe3;o dos erros de medicamentos via sondas enterais.</AbstractText><AbstractText Label="OBJETIVO" NlmCategory="OBJECTIVE">analizar el impacto de directrices sobre errores en medicamentos prescritos para administraci&#xf3;n v&#xed;a sondas enterales.</AbstractText><AbstractText Label="M&#xc9;TODO" NlmCategory="UNASSIGNED">estudio cuantitativo, en tres fases, realizado en una cl&#xed;nica m&#xe9;dica-neurolog&#xed;a y en unidad de terapia intensiva de un hospital general universitario. En la Fase 1 se elabor&#xf3;: protocolo de diluci&#xf3;n, reenvasado - transformaci&#xf3;n y administraci&#xf3;n para 294 medicamentos v&#xed;a sondas enterales; diagrama de flujo de decisi&#xf3;n; procedimientos operacionales est&#xe1;ndar de diluci&#xf3;n y reenvasado - transformaci&#xf3;n de formas farmac&#xe9;uticas orales y de administraci&#xf3;n de medicamentos v&#xed;a sondas enterales. En la Fase 2 se investig&#xf3;, retrospectivamente, errores en 872 medicamentos prescritos v&#xed;a sondas enterales, en 293 prescripciones de pacientes internados de marzo a junio. La continuaci&#xf3;n, capacitaci&#xf3;n de los equipos sobre directrices establecidas. En la Fase 3 se investig&#xf3;, prospectivamente, errores e intervenciones farmac&#xe9;uticas en 945 medicamentos prescritos v&#xed;a sondas enterales, en 292 prescripciones de pacientes internados de agosto a septiembre. Datos fueron colectados en un formulario estructurado, compilados en el programa Microsoft Office Excel(r) y se calcularon las frecuencias.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">se observaron 786 errores, 63,9% (502) en la Fase 2 y 36,1% (284) en la Fase 3. En la Fase 3 se verific&#xf3; una reducci&#xf3;n en la frecuencia de prescripci&#xf3;n de medicamentos, v&#xed;a sondas enterales, contraindicados y sin informaciones disponibles.</AbstractText><AbstractText Label="CONCLUSI&#xd3;N" NlmCategory="UNASSIGNED">las directrices e intervenciones farmac&#xe9;uticas fueron determinantes en la prevenci&#xf3;n de los errores de medicamentos v&#xed;a sondas enterales.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ferreira</LastName><ForeName>Carolina Justus Buhrer</ForeName><Initials>CJ</Initials><Suffix>Neto</Suffix><AffiliationInfo><Affiliation>MSc, Assistant Professor, Departamento de Ci&#xea;ncias Farmac&#xea;uticas, Universidade Estadual de Ponta Grossa, Ponta Grossa, PR, Brazil. , Universidade Estadual de Ponta Grossa, Departamento de Ci&#xea;ncias Farmac&#xea;uticas, Universidade Estadual de Ponta Grossa, Ponta Grossa PR , Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plodek</LastName><ForeName>Caroline Koga</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Pharmacists, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soares</LastName><ForeName>Franciny Kossemba</ForeName><Initials>FK</Initials><AffiliationInfo><Affiliation>Pharmacists, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrade</LastName><ForeName>Rayza Assis de</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Pharmacist, Student, curso de "Resid&#xea;ncia Multiprofissional em Sa&#xfa;de do Idoso", Hospital Universit&#xe1;rio Regional dos Campos Gerais, Universidade Estadual de Ponta Grossa, Ponta Grossa, PR, Brazil. , Universidade Estadual de Ponta Grossa, Hospital Universit&#xe1;rio Regional dos Campos Gerais, Universidade Estadual de Ponta Grossa, Ponta Grossa PR , Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teleginski</LastName><ForeName>Fernanda</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Undergraduate student in Pharmaceutics, Universidade Estadual de Ponta Grossa, Ponta Grossa, PR, Brazil., Universidade Estadual de Ponta Grossa, Universidade Estadual de Ponta Grossa, Ponta Grossa PR , Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rocha</LastName><ForeName>Maria Dagmar da</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Assistant Professor, Departamento de Enfermagem e Sa&#xfa;de P&#xfa;blica, Universidade Estadual de Ponta Grossa, Ponta Grossa, PR, Brazil., Universidade Estadual de Ponta Grossa, Departamento de Enfermagem e Sa&#xfa;de P&#xfa;blica, Universidade Estadual de Ponta Grossa, Ponta Grossa PR , Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>por</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Rev Lat Am Enfermagem</MedlineTA><NlmUniqueID>9420934</NlmUniqueID><ISSNLinking>0104-1169</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D055553">Prescription Drugs</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName UI="D002985" MajorTopicYN="N">Clinical Protocols</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004333" MajorTopicYN="N">Drug Administration Routes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006784" MajorTopicYN="N">Hospitals, Teaching</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007441" MajorTopicYN="N">Intubation, Gastrointestinal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008508" MajorTopicYN="N">Medication Errors</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055553" MajorTopicYN="N">Prescription Drugs</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>6</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27276019</ArticleId><ArticleId IdType="pmc">PMC4915797</ArticleId><ArticleId IdType="doi">10.1590/1518-8345.0619.2696</ArticleId><ArticleId IdType="pii">S0104-11692016000100329</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carvalho AMR, Oliveira DC, H JE, Neto, Martins BCC, Vieira VMSF, Silva LIMM. An&#xe1;lise da prescri&#xe7;&#xe3;o de pacientes utilizando sonda enteral em um hospital universit&#xe1;rio do Cear&#xe1;. Rev Bras Farm Hosp Serv Sa&#xfa;de. 2010;1(1):17&#x2013;21.</Citation></Reference><Reference><Citation>Gorzoni ML, Torre AD, Pires SL. Medicamentos e sondas de nutri&#xe7;&#xe3;o. Rev Assoc Med Bras. 2010;56(1):17&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">20339780</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva MJS, Cava CEM, Pedroso PK, Futuro DO. Evaluation of the profile of drug therapy administered through enteral feeding tube in a general hospital in Rio de Janeiro. RBCF. 2011;47(2):331&#x2013;337.</Citation></Reference><Reference><Citation>Rodrigues JB, Martins FJ, Raposo NRB, Chicourel EL. Perfil de utiliza&#xe7;&#xe3;o de medicamentos por sonda enteral em pacientes de um hospital universit&#xe1;rio. Rev Bras Farm Hosp Serv Sa&#xfa;de. 2014;5(3):23&#x2013;27.</Citation></Reference><Reference><Citation>Lima G, Negrini NMM. Assist&#xea;ncia farmac&#xea;utica na administra&#xe7;&#xe3;o de medicamentos via sonda escolha da forma farmac&#xea;utica adequada. Einstein. 2009;7:9&#x2013;17.</Citation></Reference><Reference><Citation>Williams NT. Medication administration through enteral feeding tubes. Am J Health Syst Pharm. 2008;65:2347&#x2013;2357.</Citation><ArticleIdList><ArticleId IdType="pubmed">19052281</ArticleId></ArticleIdList></Reference><Reference><Citation>Heldt T, Loss SH. Intera&#xe7;&#xe3;o f&#xe1;rmaco-nutriente em unidade de terapia intensiva revis&#xe3;o da literatura e recomenda&#xe7;&#xf5;es atuais. Rev Bras Ter Intensiva. 2013;25(2):162&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4031824</ArticleId><ArticleId IdType="pubmed">23917982</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento MMG, Ribeiro AQ. Compila&#xe7;&#xe3;o de base de dados com recomenda&#xe7;&#xf5;es para administra&#xe7;&#xe3;o de medicamentos via sonda enteral. Rev Bras Farm Hosp Serv Sa&#xfa;de. 2010;1(1):22&#x2013;25.</Citation></Reference><Reference><Citation>Moriel P, Shoji P, Bortoletto TC, Mazzola PG. Uso off label de medicamentos atrav&#xe9;s de sondas diverg&#xea;ncia entre informa&#xe7;&#xf5;es. Rev Bras Farm Hosp Serv Sa&#xfa;de. 2012;3(2):20&#x2013;24.</Citation></Reference><Reference><Citation>Lisboa CD, Silva LD, Matos GC. Investiga&#xe7;&#xe3;o da t&#xe9;cnica de preparo de medicamentos para administra&#xe7;&#xe3;o por cateteres pela enfermagem na terapia intensiva. Rev Esc Enferm USP. 2013;47(1):53&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">23515803</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso AP, Pinheiro MS. Avalia&#xe7;&#xe3;o dos medicamentos prescritos para pacientes submetidos &#xe0; terapia nutricional enteral no CTI. Rev Bras Farm Hosp Serv Sa&#xfa;de. 2014;5(1):12&#x2013;18.</Citation></Reference><Reference><Citation>Santos CM, Costa JM, Queiroz Netto MU, Reis AMM, Castro MS. Acompanhamento farmacoterap&#xea;utico de pacientes em uso de sonda nasoenteral em um hospital de ensino. Rev Bras Farm Hosp Serv Sa&#xfa;de. 2012;3(1):19&#x2013;22.</Citation></Reference><Reference><Citation>Mota MLS, Barbosa IV, Studart RMB, Melo EM, Lima FET, Mariano FA. Evaluation of intensivist-nurses' knowledge concerning medication administration through nasogastric and enteral tubes. Rev. Latino-Am. Enfermagem. 2010;18(5):888&#x2013;894.</Citation><ArticleIdList><ArticleId IdType="pubmed">21120407</ArticleId></ArticleIdList></Reference><Reference><Citation>Heydrich J, Heineck I, Bueno D. Observation of preparation and administration of drugs by nursing assistants in patients with enteral feeding tube. RBCF. 2009;45(1):117&#x2013;120.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>